56 research outputs found
Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish
The zebrafish has become an important model for cancer research. Several cancer models have been established by transgenic expression of human or mouse oncogenes in zebrafish. Since it is amenable to efficient transgenesis, zebrafish have immense potential to be used for studying interaction of oncogenes and pathways at the organismal level. Using the Gal4VP16-UAS binary transgenic expression approach, we established stable transgenic lines expressing an EGFP fusion protein of an activated zebrafish Smoothened (Smoa1-EGFP). Expression of the zebrafish Smoa1-EGFP itself did not lead to tumor formation either in founder fish or subsequent generations, however, co-expressing a constitutively active human AKT1 resulted in several tumor types, including spindle cell sarcoma, rhabdomyoma, ocular melanoma, astrocytoma, and myoxma. All tumor types showed GFP expression and increased Patched 1 levels, suggesting involvement of zebrafish Smoa1 in tumorigenesis. Immunofluorescence studies showed that tumors also expressed elevated levels of phosphorylated AKT, indicating activation of the PI3K-AKT pathway. These results suggest that co-activation of the hedgehog and AKT pathways promote tumorigenesis, and that the binary transgenic approach is a useful tool for studying interaction of oncogenes and oncogenic pathways in zebrafish
Recommended from our members
Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish
The zebrafish has become an important model for cancer research. Several cancer models have
been established by transgenic expression of human or mouse oncogenes in zebrafish. Since it is
amenable to efficient transgenesis, zebrafish have immense potential to be used for studying
interaction of oncogenes and pathways at the organismal level. Using the Gal4VP16-UAS binary
transgenic expression approach, we established stable transgenic lines expressing an EGFP fusion
protein of an activated zebrafish Smoothened (Smoa1-EGFP). Expression of the zebrafish Smoa1-EGFP itself did not lead to tumor formation either in founder fish or subsequent generations,
however, co-expressing a constitutively active human AKT1 resulted in several tumor types,
including spindle cell sarcoma, rhabdomyoma, ocular melanoma, astrocytoma, and myoxma. All
tumor types showed GFP expression and increased Patched 1 levels, suggesting involvement of
zebrafish Smoa1 in tumorigenesis. Immunofluorescence studies showed that tumors also expressed
elevated levels of phosphorylated AKT, indicating activation of the PI3K-AKT pathway. These
results suggest that co-activation of the hedgehog and AKT pathways promote tumorigenesis, and
that the binary transgenic approach is a useful tool for studying interaction of oncogenes and
oncogenic pathways in zebrafish
A Lectin HPLC Method to Enrich Selectively-glycosylated Peptides from Complex Biological Samples
Glycans are an important class of post-translational modifications. Typically found on secreted and extracellular molecules, glycan structures signal the internal status of the cell. Glycans on tumor cells tend to have abundant sialic acid and fucose moieties. We propose that these cancer-associated glycan variants be exploited for biomarker development aimed at diagnosing early-stage disease. Accordingly, we developed a mass spectrometry-based workflow that incorporates chromatography on affinity matrices formed from lectins, proteins that bind specific glycan structures. The lectins Sambucus nigra (SNA) and Aleuria aurantia (AAL), which bind sialic acid and fucose, respectively, were covalently coupled to POROS beads (Applied Biosystems) and packed into PEEK columns for high pressure liquid chromatography (HPLC). Briefly, plasma was depleted of the fourteen most abundant proteins using a multiple affinity removal system (MARS-14; Agilent). Depleted plasma was trypsin-digested and separated into flow-through and bound fractions by SNA or AAL HPLC. The fractions were treated with PNGaseF to remove N-linked glycans, and analyzed by LC-MS/MS on a QStar Elite. Data were analyzed using Mascot software. The experimental design included positive controls—fucosylated and sialylated human lactoferrin glycopeptides—and negative controls—high mannose glycopeptides from Saccharomyces cerevisiae—that were used to monitor the specificity of lectin capture. Key features of this workflow include the reproducibility derived from the HPLC format, the positive identification of the captured and PNGaseF-treated glycopeptides from their deamidated Asn-Xxx-Ser/Thr motifs, and quality assessment using glycoprotein standards. Protocol optimization also included determining the appropriate ratio of starting material to column capacity, identifying the most efficient capture and elution buffers, and monitoring the PNGaseF-treatment to ensure full deglycosylation. Future directions include using this workflow to perform mass spectrometry-based discovery experiments on plasma from breast cancer patients and control individuals
Recommended from our members
Oncogenic KRAS promotes malignant brain tumors in zebrafish
BACKGROUND: Zebrafish have been used as a vertebrate model to study human cancers such as melanoma,
rhabdomyosarcoma, liver cancer, and leukemia as well as for high-throughput screening of small molecules of
therapeutic value. However, they are just emerging as a model for human brain tumors, which are among the most
devastating and difficult to treat. In this study, we evaluated zebrafish as a brain tumor model by overexpressing a
human version of oncogenic KRAS (KRAS[superscript G12V]).
METHODS: Using zebrafish cytokeratin 5 (krt5) and glial fibrillary acidic protein (gfap) gene promoters, we activated
Ras signaling in the zebrafish central nervous system (CNS) through transient and stable transgenic overexpression.
Immunohistochemical analyses were performed to identify activated pathways in the resulting brain tumors. The
effects of the MEK inhibitor U0126 on oncogenic KRAS were evaluated.
RESULTS: We demonstrated that transient transgenic expression of KRAS[superscript G12V] in putative neural stem and/or progenitor cells induced brain tumorigenesis. When expressed under the control of the krt5 gene promoter, KRAS[superscript G12V] induced brain tumors in ventricular zones (VZ) at low frequency. The majority of other tumors were composed mostly of spindle and epithelioid cells, reminiscent of malignant peripheral nerve sheath tumors (MPNSTs). In contrast, when expressed under the control of the gfap gene promoter, KRAS[superscript G12V] induced brain tumors in both VZs and brain parenchyma at higher frequency. Immunohistochemical analyses indicated prominent activation of the canonical RAS-RAF-ERK pathway, variable activation of the mTOR pathway, but no activation of the PI3K-AKT pathway. In a krt5-derived stable and inducible transgenic line, expression of oncogenic KRAS resulted in skin hyperplasia, and the MEK inhibitor U0126 effectively suppressed this pro-proliferative effects. In a gfap-derived stable and inducible line, expression of oncogenic KRAS led to significantly increased mitotic index in the spinal cord.
CONCLUSIONS: Our studies demonstrate that zebrafish could be explored to study cellular origins and molecular
mechanisms of brain tumorigenesis and could also be used as a platform for studying human oncogene function and
for discovering oncogenic RAS inhibitors.Keywords: gfap, krt5, Oncogenic KRAS (KRAS[superscript G12V]), Zebrafish, Drug screening, Brain tumor
MRI of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries
This study was to validate the feasibility of using clinical 3.0T MRI to monitor the migration of autotransplanted bone marrow (BM)-derived stem-progenitor cells (SPC) to the injured arteries of near-human sized swine for potential cell-based arterial repair.The study was divided into two phases. For in vitro evaluation, BM cells were extracted from the iliac crests of 13 domestic pigs and then labeled with a T2 contrast agent, Feridex, and/or a fluorescent tissue marker, PKH26. The viability, the proliferation efficiency and the efficacies of Feridex and/or PKH26 labeling were determined. For in vivo validation, the 13 pigs underwent endovascular balloon-mediated intimal damages of the iliofemoral arteries. The labeled or un-labeled BM cells were autotransplanted back to the same pig from which the BM cells were extracted. Approximately three weeks post-cell transplantation, 3.0T T2-weighted MRI was performed to detect Feridex-created signal voids of the transplanted BM cells in the injured iliofemoral arteries, which was confirmed by subsequent histologic correlation.Of the in vitro study, the viability of dual-labeled BM cells was 95-98%. The proliferation efficiencies of dual-labeled BM cells were not significantly different compared to those of non-labeled cells. The efficacies of Feridex- and PKH26 labeling were 90% and 100%, respectively. Of the in vivo study, 3.0T MRI detected the auto-transplanted BM cells migrated to the injured arteries, which was confirmed by histologic examinations.This study demonstrates the capability of using clinical 3.0T MRI to monitor the auto-transplantation of BM cells that migrate to the injured arteries of large animals, which may provide a useful MRI technique to monitor cell-based arterial repair
Genome, Functional Gene Annotation, and Nuclear Transformation of the Heterokont Oleaginous Alga \u3ci\u3eNannochloropsis oceanica\u3c/i\u3e CCMP1779
Unicellular marine algae have promise for providing sustainable and scalable biofuel feedstocks, although no single species has emerged as a preferred organism. Moreover, adequate molecular and genetic resources prerequisite for the rational engineering of marine algal feedstocks are lacking for most candidate species. Heterokonts of the genus Nannochloropsis naturally have high cellular oil content and are already in use for industrial production of high-value lipid products. First success in applying reverse genetics by targeted gene replacement makes Nannochloropsis oceanica an attractive model to investigate the cell and molecular biology and biochemistry of this fascinating organism group. Here we present the assembly of the 28.7 Mb genome of N. oceanica CCMP1779. RNA sequencing data from nitrogen-replete and nitrogendepleted growth conditions support a total of 11,973 genes, of which in addition to automatic annotation some were manually inspected to predict the biochemical repertoire for this organism. Among others, more than 100 genes putatively related to lipid metabolism, 114 predicted transcription factors, and 109 transcriptional regulators were annotated. Comparison of the N. oceanica CCMP1779 gene repertoire with the recently published N. gaditana genome identified 2,649 genes likely specific to N. oceanica CCMP1779. Many of these N. oceanica–specific genes have putative orthologs in other species or are supported by transcriptional evidence. However, because similarity-based annotations are limited, functions of most of these species-specific genes remain unknown. Aside from the genome sequence and its analysis, protocols for the transformation of N. oceanica CCMP1779 are provided. The availability of genomic and transcriptomic data for Nannochloropsis oceanica CCMP1779, along with efficient transformation protocols, provides a blueprint for future detailed gene functional analysis and genetic engineering of Nannochloropsis species by a growing academic community focused on this genus
Erratum: Semiâ automated pulmonary nodule interval segmentation using the NLST data
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/144604/1/mp12905_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/144604/2/mp12905.pd
Transient expression of two luciferase reporter gene constructs in developing embryos of Macrobrachium lanchesteri (De Man)
Aquaculture Research283183-190AQRE
Recommended from our members
SpitsbergenJanMicrobiologyCo-ActivationHedgehogAKT.pdf
The zebrafish has become an important model for cancer research. Several cancer models have
been established by transgenic expression of human or mouse oncogenes in zebrafish. Since it is
amenable to efficient transgenesis, zebrafish have immense potential to be used for studying
interaction of oncogenes and pathways at the organismal level. Using the Gal4VP16-UAS binary
transgenic expression approach, we established stable transgenic lines expressing an EGFP fusion
protein of an activated zebrafish Smoothened (Smoa1-EGFP). Expression of the zebrafish Smoa1-EGFP itself did not lead to tumor formation either in founder fish or subsequent generations,
however, co-expressing a constitutively active human AKT1 resulted in several tumor types,
including spindle cell sarcoma, rhabdomyoma, ocular melanoma, astrocytoma, and myoxma. All
tumor types showed GFP expression and increased Patched 1 levels, suggesting involvement of
zebrafish Smoa1 in tumorigenesis. Immunofluorescence studies showed that tumors also expressed
elevated levels of phosphorylated AKT, indicating activation of the PI3K-AKT pathway. These
results suggest that co-activation of the hedgehog and AKT pathways promote tumorigenesis, and
that the binary transgenic approach is a useful tool for studying interaction of oncogenes and
oncogenic pathways in zebrafish
- …